QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
ASX:IME

ImExHS (IME) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.09 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ImExHS

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. It offers a medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; Antero, a cardiology software solution; and STELLA AI, a set of artificial intelligence tools that support specialists in the diagnosis. It also provides outsourced radiology services for hospitals and other establishments, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is headquartered in Mascot, Australia.

IME Stock News Headlines

Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Insider Stock Buying Reaches AU$1.1m On ImExHS
Radiology Services Global Market Report 2023
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Breakeven Is Near for ImExHS Limited (ASX:IME)
INDUS Announces Fiscal 2021 Third Quarter Earnings Call
See More Headlines
Receive IME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImExHS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Today
4/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
400
Year Founded
N/A

Profitability

Net Income
$-4,190,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$19.89 million
Book Value
A$0.38 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
1.28
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. German Arango
    Co-Founder, CEO, MD & Director
  • Ms. Reena Minhas ACA
    CFO & Company Secretary
  • Dr. Jorge H-Marin Munoz
    Co-Founder & Chief Medical Officer
  • Mr. Andres Vanegas
    Co-Founder & Strategic Accounts Manager
  • Mr. Alexander Sanz
    Co-Founder & CTO
  • Mr. Orlando Joven
    Chief Operating Officer
  • Mr. Juan Sebastian Bonnet
    Head of Sales
  • Mr. Benjamin Brinquis
    Head of Growth

IME Stock Analysis - Frequently Asked Questions

How were ImExHS's earnings last quarter?

ImExHS Limited (ASX:IME) issued its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. ImExHS had a negative trailing twelve-month return on equity of 26.30% and a negative net margin of 21.08%.

This page (ASX:IME) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners